Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/17/09 |
Boston
|
|
New Owner Laying Off a Quarter of Indevus Pharma Employees
|
Ryan McBride |
06/10/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Deux Deals for Dyax, Au Revoir for Vertex’s Boger, Grande Alliance for Idenix and GSK, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
02/11/09 |
Boston
|
|
Indevus: Mixed Results with HIV Blocker
|
Ryan McBride |
02/09/09 |
Boston
|
|
Archemix Partners with GSK, EMC Acquires SourceLabs Assets, Satori Raises $22M to Take on Alzheimer’s, & More Boston-Area Deals News
|
Rebecca Zacks |
01/09/09 |
Boston
|
|
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/07/09 |
Boston
|
|
Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo
|
Luke Timmerman |
01/05/09 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/08 |
Boston
|
|
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
|
Ryan McBride |
09/30/08 |
Boston
|
|
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News
|
Rebecca Zacks |
09/02/08 |
Boston
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
Boston
|
|
Indevus Pharma Raises $105M in Debt Sale
|
Ryan McBride |
08/26/08 |
Boston
|
|
Vertex Cashes Out HIV Drugs, FDA Smiles on Infinity and Frowns on Indevus, Alnylam Makes Cross-Border Investment, & More Life Sciences News
|
Rebecca Zacks |
06/05/08 |
Boston
|
|
Indevus Drug Delayed by FDA Safety Questions, Shares Plummet
|
Luke Timmerman |
06/04/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
